Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical. Read More
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31, 2020 (Q3FY21). ...
The Drug Regulatory Authority of Pakistan (Drap) on Monday approved Chinese state-owned firm Sinopharm's COVID-19 vaccine for emergency use, the second vaccine to be given approval for use in the country, reported Dawn. ...
Pakistan has not placed any final order to import the Covid-19 vaccine nor has any vaccine manufacturer accepted the country's request for supply of the vaccine, a top official in the Imran Khan government has said. ...
Pakistan has not placed any final order to import the Covid-19 vaccine nor has any vaccine manufacturer accepted the country's request for supply of the vaccine, a top official in the Imran Khan government has said. ...